VIC Session - Navigating Commercialisation Challenges: Where Are You on Your Journey?

In collaboration with EY and ABPI.

As funding is increasingly difficult to secure, finding new ways to maximise income has become ever more important, and operational barriers and agreements based on outcomes can pose challenges to your ability to scale. Building a roadmap based on insights is essential for success.

Discussion will centre around the commercial roadmap, collaboration at a pan-industry level and the opportunity for value-based contracting to overcome commercialisation challenges. 

1. Commercialisation challenges
Approximately 70% of drug launches fail to meet their commercial expectations and this is number is likely to grow as an increasing amount of early-stage therapy developers are expected to take their innovation all the way through the clinic and to the market. Does your company appreciate the skills and resources that are required for you to coordinate clinical activities, gain regulatory approval and successfully deploy in multiple healthcare systems around the world?

 Topics covered in this session will include:

• Challenges in launching drugs amid a rapidly landscape commercial landscape
• Factors to consider to boost chances of success
• Use of enabling tools, technologies & methodologies

 Session delivered by Rory Dunne, Senior Manager in EY’s Commercial Excellence and Irish Medtech Lead

2. Value based contacting for commercialisation
Prepare your company for a new world, where pricing & reimbursement could be derived from value-based contracts that create a dynamic link between the clinical and economic value a therapy delivers over time. Have you considered the impact that this will have on your product and what evidence generation activities might help you to convince regulators, payers and potential acquirers?

 Topics covered in this session will include:

• Environmental analysis & overview of pricing & market access challenges
• Innovative contracting solutions & EY Health Outcomes
• Ecosystem collaboration & news ways of working

Session delivered by Jenny Hughes, Director in EY’s Commercial Excellence

3. Fireside Chat – Payment and reimbursement, opportunities and challenges

Discussion around the proactive inclusion of pricing & reimbursement considerations as part of your clinical planning, to ensure that payers and potential acquirers alike recognise the value of your innovative therapy

Participation from:

• Jenny Hughes, Senior Manager in EY’s Commercial Excellence
• Paul Catchpole, Value & Access Director at Association of the British Pharmaceutical Industry
• A.N Other

4. Apps, devices and wearables – navigating the clinical and regulatory requirements

Session led by Alex Charitou, EY

To request an invitation please email Ruby Sharoon-Khan rsharoonkhan@uk.ey.com